Systematic review and guide to management of core and psychiatric symptoms in youth with autism
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Objective: Evidence‐based guidance of clinical decision‐making for the management of Autism Spectrum Disorder (ASD) is lacking, particularly for co‐occurring psychiatric symptoms. This review evaluates treatment evidence for six common symptom targets in children/adolescents with ASD and provides a resource to facilitate application of the evidence to clinical practice. Method: A systematic search identified randomized controlled trials (RCT s) and high‐quality systematic reviews published between 2007 and 2016, focused on: social interaction/communication impairment, stereotypic/repetitive behaviours, irritability/agitation, attention‐deficit/hyperactivity disorder symptoms, mood or anxiety symptoms, and sleep difficulties. We then completed qualitative evaluation of high‐quality systematic reviews/meta‐analyses and quantitative evaluation of recently published RCT s not covered by prior comprehensive systematic reviews. Results: Recently published RCT s focused on social interaction and communication impairment (trials = 32) using psychosocial interventions. Interventions for irritability/agitation (trials = 16) were mainly pharmacological. Few RCT s focused on other symptom targets (trials = 2–5/target). Integration of these results with our qualitative review indicated that few established treatment modalities exist, and available evidence is limited by small studies with high risk of bias. Conclusion: Given the current evidence‐base, treatment targets must be clearly defined, and a systematic approach to intervention trials in children/adolescents with ASD must be undertaken with careful consideration of the limitations of safety/efficacy data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179964f · Cited by 3,399
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis
Loomes, R., Hull, L., & Mandy, W. P. L. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.03.013 · Cited by 2,804
Global Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
Lai, M.-C., Lombardo, M. V., & Baron-Cohen, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61539-1 · Cited by 2,371
Self-citationIdentification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Anxiety in children and adolescents with autism spectrum disorders
White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.003 · Cited by 1,427
The epidemiology and global burden of autism spectrum disorders
Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheurer, R. W., Vos, T., & Scott, J. G. (2015) · Psychological Medicine · doi:10.1017/s003329171400172x · Cited by 1,224 · cited 1×
“Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition that is prevalent in the general population (1, 2).”
BackgroundManagement of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Kasari, C., Freeman, S., & Paparella, T. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01567.x · Cited by 951
Green, J., Charman, T., McConachie, H., Aldred, C., Slonims, V., Howlin, P., Le Couteur, A., Leadbitter, K., Hudry, K., Byford, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60587-9 · Cited by 857
A Systematic Review of Early Intensive Intervention for Autism Spectrum Disorders
Warren, Z., McPheeters, M. L., Sathe, N., Foss-Feig, J. H., Glasser, A., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0426 · Cited by 790
Self-citationRandomized Controlled Caregiver Mediated Joint Engagement Intervention for Toddlers with Autism
Kasari, C., Gulsrud, A. C., Wong, C., Kwon, S., & Locke, J. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-0955-5 · Cited by 751
Rogers, S. J., Estes, A., Lord, C., Vismara, L., Winter, J., Fitzpatrick, A., Guo, M., & Dawson, G. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.003 · Cited by 713
Wood, J. J., Drahota, A., Sze, K., Har, K., Chiu, A., & Langer, D. A. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01948.x · Cited by 666
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613
Systematic Review of Early Intensive Behavioral Interventions for Children With Autism
Howlin, P., Magiati, I., & Charman, T. (2009) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/2009.114:23-41 · Cited by 572 · cited 1×
“Reviews of early intensive behavioural interventions (EIBI) that provide intensive intervention (10–40 h/week) to young children with ASD (~2–5 year-olds) using applied behavioural analysis (ABA) principles mainly showed effects on IQ and adaptive behaviour in ASD (24, 25, 30, 32, 87).”
MethodThe Effect of Therapeutic Horseback Riding on Social Functioning in Children with Autism
Bass, M. M., Duchowny, C. A., & Llabre, M. M. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0734-3 · Cited by 545
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482 · cited 2×
“For pharmacological interventions evaluated by the NICE guideline (18), meta-analysis of two studies (110, 111) that examined the selective serotonin reuptake inhibitors (SSRIs) fluoxetine (111) and citalopram (110), respectively, compared to placebo, found no effect of SSRI treatment on scales measuring compulsions o…”
BackgroundMethodMelatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 1×
“Additional systematic reviews (199, 200) also found some evidence for the efficacy of melatonin in ASD, with little to no adverse events reported (199, 200).”
BackgroundJoshi, G., Petty, C., Wozniak, J., Henin, A., Fried, R., Galdo, M., Kotarski, M., Walls, S., & Biederman, J. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-0996-9 · Cited by 464 · cited 1×
“Treatment principles for psychiatric symptom targets in non-ASD children/adolescents may not be generalizable to those with ASD, as exemplified by data indicating that treatment response may be lower in ASD and side-effect burden higher with some treatments (13, 14).”
BackgroundBearss, K., Johnson, C., Smith, T., Lecavalier, L., Swiezy, N., Aman, M., McAdam, D. B., Butter, E., Stillitano, C., Minshawi, N., et al. (2015) · JAMA · doi:10.1001/jama.2015.3150 · Cited by 454 · cited 3×
“Parent training (10 weekly sessions) for this study was adapted from the RUPP parent training manual focusing on preventing behaviour problems, time-outs, planned ignoring and reinforcement (151).”
BackgroundMethodA randomized controlled trial of Hanen's ‘More Than Words’ in toddlers with early autism symptoms
Carter, A. S., Messinger, D. S., Stone, W. L., Celimli, S., Nahmias, A. S., & Yoder, P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02395.x · Cited by 446 · cited 1×
“treatment as usual in young children with ASD showed small significant effects in favour of the intervention on: social interaction (two studies, low quality) (58, 62), number of communication acts (three studies, low quality) (58, 59, 62) and increased joint shared attention (five studies, moderate quality (58, 62, 6…”
BackgroundChalfant, A. M., Rapee, R., & Carroll, L. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0318-4 · Cited by 428
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415
Kasari, C., Kaiser, A., Goods, K., Nietfeld, J., Mathy, P., Landa, R., Murphy, S., & Almirall, D. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.01.019 · Cited by 415
Anxiety, social deficits, and loneliness in youth with autism spectrum disorders
White, S. W., & Roberson-Nay, R. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0713-8 · Cited by 399 · cited 1×
“Systematic reviews (177, 193) mention preliminary evidence for the efficacy of dextromethorphan (194) and buspirone (195) based on small studies without a control group.”
BackgroundBeaumont, R., & Sofronoff, K. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01920.x · Cited by 384
Medical Comorbidities in Autism: Challenges to Diagnosis and Treatment
Bauman, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.06.001 · Cited by 372
Aman, M. G., Mcdougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., Stigler, K. A., Bearss, K., Butter, E., Swiezy, N. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181bfd669 · Cited by 371 · cited 1×
“lack of blinding, small sample size) (109).”
Landa, R. J., Holman, K. C., O’Neill, A. H., & Stuart, E. A. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02288.x · Cited by 353
Drew, A., Baird, G., Baron-Cohen, S., Cox, A., Slonims, V., Wheelwright, S., Swettenham, J., Berry, B., & Charman, T. (2002) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-002-0299-6 · Cited by 325
Tanaka, J. W., Wolf, J. M., Klaiman, C., Koenig, K., Cockburn, J., Herlihy, L., Brown, C., Stahl, S., Kaiser, M. D., & Schultz, R. T. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02258.x · Cited by 318
Guastella, A. J., Gray, K. M., Rinehart, N. J., Alvares, G. A., Tonge, B. J., Hickie, I. B., Keating, C. M., Cacciotti‐Saija, C., & Einfeld, S. L. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12305 · Cited by 299 · cited 2×
“placebo on social communication scores in ASD (101).”
BackgroundTONGE, B., BRERETON, A., KIOMALL, M., MACKINNON, A., KING, N., & RINEHART, N. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000205701.48324.26 · Cited by 298
Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., Coury, D., Whitaker, A., Veenstra-Vanderweele, J., & Hardan, A. Y. (2016) · Pediatrics · doi:10.1542/peds.2015-2851k · Cited by 294
Self-citationStorch, E. A., Arnold, E. B., Lewin, A. B., Nadeau, J. M., Jones, A. M., De Nadai, A. S., Jane Mutch, P., Selles, R. R., Ung, D., & Murphy, T. K. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.11.007 · Cited by 267 · cited 2×
“Three of the four small CBT studies evaluated (189, 197, 198) demonstrated statistical significance on anxiety outcomes of interest (all SMD > 0.”
BackgroundResultWhiteley, P., Haracopos, D., Knivsberg, A.-M., Reichelt, K. L., Parlar, S., Jacobsen, J., Seim, A., Pedersen, L., Schondel, M., & Shattock, P. (2010) · Nutritional Neuroscience · doi:10.1179/147683010x12611460763922 · Cited by 266
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Cognitive-Behavioral Therapy for Anxiety in Children With High-Functioning Autism: A Meta-analysis
Sukhodolsky, D. G., Bloch, M. H., Panza, K. E., & Reichow, B. (2013) · Pediatrics · doi:10.1542/peds.2013-1193 · Cited by 234
Ung, D., Selles, R., Small, B. J., & Storch, E. A. (2015) · Child Psychiatry & Human Development · doi:10.1007/s10578-014-0494-y · Cited by 231
Wood, J. J., Ehrenreich-May, J., Alessandri, M., Fujii, C., Renno, P., Laugeson, E., Piacentini, J. C., De Nadai, A. S., Arnold, E., Lewin, A. B., et al. (2015) · Behavior Therapy · doi:10.1016/j.beth.2014.01.002 · Cited by 229
Lang, R., Regester, A., Lauderdale, S., Ashbaugh, K., & Haring, A. (2010) · Developmental Neurorehabilitation · doi:10.3109/17518420903236288 · Cited by 226
Naltrexone in autistic children: Behavioral symptoms and attentional learning
CAMPBELL, M., ANDERSON, L. T., SMALL, A. M., ADAMS, P., GONZALEZ, N. M., & ERNST, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199311000-00024 · Cited by 210 · cited 1×
“In addition, single study data found no evidence of effect for citalopram (110), amantadine (140), naltrexone (138) or atomoxetine (141) on irritability/agitation; however, evidence quality was largely low.”
BackgroundRahman, A., Divan, G., Hamdani, S. U., Vajaratkar, V., Taylor, C., Leadbitter, K., Aldred, C., Minhas, A., Cardozo, P., Emsley, R., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00388-0 · Cited by 203 · cited 2×
“Most recently published psychosocial interventions provided single study data evaluating unique intervention approaches with the exception of parent-mediated (three trials) (91, 93, 95) and computer-based (three trials) (94, 96, 99) approaches.”
BackgroundExtended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder
Scahill, L., McCracken, J. T., King, B. H., Rockhill, C., Shah, B., Politte, L., Sanders, R., Minjarez, M., Cowen, J., Mullett, J., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010055 · Cited by 201
Spreckley, M., & Boyd, R. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.09.012 · Cited by 195
Use of psychotropic medication in children and adolescents with autism spectrum disorders
Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900d · Cited by 191 · cited 1×
“Among 2843 youth in the Autism Speaks Autism Treatment Network (AS-ATN), 46% of 6– 11-year-olds and 66% of 12–17-year-olds with ASD were prescribed psychotropic medications (15).”
BackgroundSelf-citationA Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders
Vasa, R. A., Carroll, L. M., Nozzolillo, A. A., Mahajan, R., Mazurek, M. O., Bennett, A. E., Wink, L. K., & Bernal, M. P. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2184-9 · Cited by 168 · cited 2×
“In one review (177), this conclusion was based on an effect size of >0.”
BackgroundKasari, C., Dean, M., Kretzmann, M., Shih, W., Orlich, F., Whitney, R., Landa, R., Lord, C., & King, B. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12460 · Cited by 159
A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder
Bent, S., Bertoglio, K., Ashwood, P., Bostrom, A., & Hendren, R. L. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1078-8 · Cited by 156
Handen, B. L., Aman, M. G., Arnold, L. E., Hyman, S. L., Tumuluru, R. V., Lecavalier, L., Corbett-Dick, P., Pan, X., Hollway, J. A., Buchan-Page, K. A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.013 · Cited by 147
Self-citationReichow, B., Volkmar, F. R., & Bloch, M. H. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1793-z · Cited by 134 · cited 3×
“(164) came to similar conclusions regarding potential utility of methylphenidate treatment for ADHD symptoms in ASD.”
BackgroundMethodSung, M., Ooi, Y. P., Goh, T. J., Pathy, P., Fung, D. S. S., Ang, R. P., Chua, A., & Lam, C. M. (2011) · Child Psychiatry & Human Development · doi:10.1007/s10578-011-0238-1 · Cited by 131
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub2 · Cited by 131 · cited 3×
“In addition, a 2013 Cochrane review evaluating nine studies including children/adolescents concluded that there is no evidence to support the use of SSRIs to treat core symptoms of ASD in children (108).”
BackgroundPosey, D. J., Aman, M. G., McCracken, J. T., Scahill, L., Tierney, E., Arnold, L. E., Vitiello, B., Chuang, S. Z., Davies, M., Ramadan, Y., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.028 · Cited by 131
Anagnostou, E., Aman, M. G., Handen, B. L., Sanders, K. B., Shui, A., Hollway, J. A., Brian, J., Arnold, L. E., Capano, L., Hellings, J. A., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1232 · Cited by 123 · cited 3×
“metformin treatment, compared treatment to placebo in children with ASD (age 6–17) who were previously treated with either risperidone or aripiprazole and who had significant weight gain since starting on antipsychotic treatment (206).”
BackgroundInfluentialSelf-citationDeRosier, M. E., Swick, D. C., Davis, N. O., McMillen, J. S., & Matthews, R. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1128-2 · Cited by 113
Buitelaar, J. K., van der Gaag, R. J., & van der Hoeven, J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0203 · Cited by 113
ASD, a Psychiatric Disorder, or Both? Psychiatric Diagnoses in Adolescents with High-Functioning ASD
Mazefsky, C. A., Oswald, D. P., Day, T. N., Eack, S. M., Minshew, N. J., & Lainhart, J. E. (2012) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2012.686102 · Cited by 111
The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?
Swartz, H. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0508e15 · Cited by 107
Roy, A., Roy, M., Deb, S., Unwin, G., & Roy, A. (2015) · Journal of Intellectual Disability Research · doi:10.1111/jir.12122 · Cited by 82 · cited 1×
“Finally, a systematic review of naltrexone (an opioid antagonist) found no evidence for treatment benefit on core ASD deficits, including stereotypic/repetitive behaviours (106).”
BackgroundGroup therapy for anxiety in children with autism spectrum disorder
McConachie, H., McLaughlin, E., Grahame, V., Taylor, H., Honey, E., Tavernor, L., Rodgers, J., Freeston, M., Hemm, C., Steen, N., et al. (2014) · Autism · doi:10.1177/1362361313488839 · Cited by 81
Mental health aspects of autistic spectrum disorders in children
Skokauskas, N., & Gallagher, L. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01423.x · Cited by 75
Effect of a ketogenic diet on autism spectrum disorder: A systematic review
Castro, K., Faccioli, L. S., Baronio, D., Gottfried, C., Perry, I. S., & dos Santos Riesgo, R. (2015) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2015.08.005 · Cited by 64 · cited 1×
“One Cochrane review of gluten/casein-free diets (two trials, with n = 35 children) (37), one systematic review of ketogenic diets (107), one Cochrane review of secretin (16 trials, with n > 900 children with ASD) (38), one Cochrane review of chelation (one trial, n = 77) (39), one Cochrane review of hyperbaric oxygen…”
Background
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Self-citationLai, M.-C., Anagnostou, E., Wiznitzer, M., Allison, C., & Baron-Cohen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30034-x · Cited by 250
Self-citationRodrigues, R., Lai, M., Beswick, A., Gorman, D. A., Anagnostou, E., Szatmari, P., Anderson, K. K., & Ameis, S. H. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13305 · Cited by 98
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis
Fraguas, D., Díaz-Caneja, C. M., Pina-Camacho, L., Moreno, C., Durán-Cutilla, M., Ayora, M., González-Vioque, E., de Matteis, M., Hendren, R. L., Arango, C., et al. (2019) · PEDIATRICS · doi:10.1542/peds.2018-3218 · Cited by 80
“The relatively small ES for supplementation strategies should be appraised in the light of a lack of effective pharmacologic treatments for most core and associated symptoms in ASD.2,3 A number of positive studies of other treatments, such as using oxytocin to target nuclear symptoms of ASD (eg, social cognition, emot…”
BackgroundInfluential
Metadata
- Authors
- Ameis, S. H., Kassee, C., Corbett‐Dick, P., Cole, L., Dadhwal, S., Lai, M. ‐., Veenstra‐VanderWeele, J., & Correll, C. U.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2018-06-14
- Volume
- 138
- Issue
- 5
- Pages
- 379-400
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2808349773
- Cited by
- 64
- References
- 66
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.